- Home
- GOVX vs SNTG Comparison
GOVX vs SNTG Comparison
Compare GOVX & SNTG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GOVX | SNTG |
|---|---|---|
| Founded | 2001 | 2009 |
| Country | United States | China |
| Employees | 19 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.2M | 6.7M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | GOVX | SNTG |
|---|---|---|
| Price | $1.00 | $2.09 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $1.00 | N/A |
| AVG Volume (30 Days) | ★ 306.3K | 5.2K |
| Earning Date | 04-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.12 | $1.60 |
| 52 Week High | $4.40 | $12.70 |
Technical Indicators
Market Signals| Indicator | GOVX | SNTG |
|---|---|---|
| Relative Strength Index (RSI) | 38.09 | 54.83 |
| Support Level | $0.96 | $1.86 |
| Resistance Level | $2.00 | $2.20 |
| Average True Range (ATR) | 0.08 | 0.10 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 35.22 | 49.97 |
Price Performance
Historical ComparisonAbout GOVX GeoVax Labs Inc.
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. The company is focused on the advancement of GEO-MVA, a Modified Vaccinia Ankara (MVA) vaccine candidate for mpox, smallpox, and other poxviruses. Its flagship clinical program in oncology is Gedeptin, a novel oncolytic solid tumor gene-directed therapy, which recently completed a multicenter Phase 1/2 clinical trial for head and neck cancers. The company is also developing GEO-CM04S1, a next-generation multi-antigen COVID-19 vaccine, which is currently being evaluated in two Phase 2 clinical trials.
About SNTG Sentage Holdings Inc.
Sentage Holdings Inc is a financial service provider. The company offers a comprehensive range of financial services across consumer loan repayment and collection management, loan recommendation, and prepaid payment network services in China.